ReviewExploration of targeted anti-tumor therapy2022

Role of PI3K/Akt/mTOR pathway in mediating endocrine resistance: concept to clinic.

Aglaia Skolariki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.